Chief Technology Officer
Heart Failure (HF) is a major public health problem responsible for significant and increasing health care expenditures, representing the most common hospital discharge diagnosis for Veterans. To address this growing burden, the Veterans Health Administration (VHA) collaborated with physIQ to monitor 100 discharged HF patients using physIQ virtual care technology (the LINK-HF study).
Peer-reviewed results from the study demonstrated that wearable biosensors, coupled with machine-learning analytics, have predictive accuracy comparable to implanted devices:
During this webinar, principal investigator Josef Stehlik, MD, MPH, reviews the study’s key findings as well as:
Dr. Stehlik also discusses the follow-up study (LINK-HF2), a randomized, multicenter clinical trial being conducted by the VHA in collaboration with physIQ. This study seeks to provide further clinical evidence for the efficacy and cost-effectiveness of this approach when included in the routine care workflow of discharged heart failure patients – including fewer hospital admissions, shorter hospital stays, and better quality of life.